What Happened?
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels.
Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism.
The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Medical Devices & Supplies - Diversified company Neogen (NASDAQ: NEOG) jumped 9.1%. Is now the time to buy Neogen? Access our full analysis report here, it’s free.
- Dental Equipment & Technology company Dentsply Sirona (NASDAQ: XRAY) jumped 6%. Is now the time to buy Dentsply Sirona? Access our full analysis report here, it’s free.
- Hospital Chains company Acadia Healthcare (NASDAQ: ACHC) jumped 8.2%. Is now the time to buy Acadia Healthcare? Access our full analysis report here, it’s free.
- Hospital Chains company Universal Health Services (NYSE: UHS) jumped 5.9%. Is now the time to buy Universal Health Services? Access our full analysis report here, it’s free.
- Research Tools & Consumables company Mettler-Toledo (NYSE: MTD) jumped 8.6%. Is now the time to buy Mettler-Toledo? Access our full analysis report here, it’s free.
Zooming In On Neogen (NEOG)
Neogen’s shares are very volatile and have had 27 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
Neogen is down 45.6% since the beginning of the year, and at $6.50 per share, it is trading 63.3% below its 52-week high of $17.71 from July 2024. Investors who bought $1,000 worth of Neogen’s shares 5 years ago would now be looking at an investment worth $202.81.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
